Codexis (NASDAQ: CDXS) revenue
Codexis reported revenue of $70.4m for fiscal 2025, 18.6% more than in fiscal 2024 ($59.3m). Since fiscal 2016 its revenue has grown by 44.1%, an average growth of 4.1% a year.
Codexis's best year of the last 10 was fiscal 2022. The biggest drop was in fiscal 2023, −49.4%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $70.4m | +18.6% | −$41.7m | −59.3% |
| 2024 | $59.3m | −15.4% | −$58.5m | −98.6% |
| 2023 | $70.1m | −49.4% | −$68.1m | −97.0% |
| 2022 | $138.6m | +32.3% | −$34.9m | −25.2% |
| 2021 | $104.8m | +51.7% | −$22.7m | −21.7% |
| 2020 | $69.1m | +0.9% | −$23.9m | −34.6% |
| 2019 | $68.5m | +13.0% | −$12.5m | −18.3% |
| 2018 | $60.6m | +21.1% | −$11.3m | −18.6% |
| 2017 | $50.0m | +2.4% | −$23.0m | −45.9% |
| 2016 | $48.8m | — | −$8.6m | −17.5% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Codexis revenue compared with its sector
By revenue for its latest fiscal year, Codexis ranks 312th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Codexis, 18.6%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 310th | Assembly Biosciences | $72.3m | 153.5% |
| 311th | Viridian Therapeutics | $70.8m | 23,359.9% |
| 312th | Codexis | $70.4m | 18.6% |
| 313th | Black Diamond Therapeutics | $70.0m | — |
| 314th | Personalis | $69.6m | −17.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Codexis
- How much revenue did Codexis make in fiscal 2025?
- Codexis reported revenue of $70.4m for fiscal 2025, compared with $59.3m in fiscal 2024.
- How much has the revenue of Codexis grown?
- Between fiscal 2016 and fiscal 2025 it went from $48.8m to $70.4m: 44.1% more, an average growth of 4.1% a year.
- What was the best year for revenue at Codexis?
- Of its last 10 fiscal years, fiscal 2022, with $138.6m.
- Where does Codexis rank in its sector by revenue?
- It ranks 312th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Codexis come from?
- From the annual report (Form 10-K) that Codexis files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Codexis files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Codexis: the Codexis page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.